NT 10-Q

TAPIMMUNE, INC.

Company: Marker Therapeutics, Inc.
Filed: May 15, 2008
Period of Report: March 31, 2008
Accession Number: 0001171520-08-000293

View Document ↗ View on SEC.gov ↗